Freestone Resources Inc. (fka FSNR)

[Sax]

Dynamis does not report its financial information. R&D expenses conducted by them are not available to the public.

I'll give you that. If "new Petrozene" showed up after the Freestone/Dynamis agreement, then this is plausible. (Not sure the timing and not going to dig through docs.

It doesn't answer what alternative explanation for potential customers testing Petrozene and not buying Petrozene is.

It's too expensive for what it does (and this includes any cases where it does nothing or doesn't do anything useful, in which case any price is too expensive).